作者:Alexey I. Ilovaisky、Valentina M. Merkulova、Elena I. Chernoburova、Marina A. Shchetinina、Diana I. Salnikova、Alexander M. Scherbakov、Igor V. Zavarzin、Alexander O. Terent’ev
DOI:10.1016/j.jsbmb.2021.106000
日期:2021.11
approach to 13,17-secoestra-1,3,5(10)-trien-17-oic acid hydrazides and their N’-(het)arylmethylene derivatives was disclosed and these novel types of secosteroids were screened for cytotoxicity against hormone-dependent human breast cancer cell line MCF-7. A number of 13,17-secoestra-1,3,5(10)-trien-17-oic acid [N’-(het)arylmethylene]hydrazides show significant cytotoxic effect comparable or superior
公开了一种对 13,17-secoestra-1,3,5(10)-trien-17-oic acid hydrazides 及其 N'-(het) 芳基亚甲基衍生物的方便和选择性的方法,并筛选了这些新型 secosteroids 的细胞毒性抗激素依赖性人乳腺癌细胞系 MCF-7。许多 13,17-secoestra-1,3,5(10)-trien-17-oic acid [N'-(het)arylmethylene]hydrazides 显示出与参考药物顺铂相当或优于参考药物的显着细胞毒性作用。化合物3l表现出最高的活性,IC 50值约为 2 μM,是顺铂的 2.8 倍。Hit 13,17-secoestra-1,3,5(10)-trien-17-oic acid [N'-(het)arylmethylene]hydrazides 3d , 3l and 3q其特点是对 MCF-7 乳腺癌